LQDA
Price
$12.89
Change
+$0.38 (+3.04%)
Updated
Jan 17 closing price
Capitalization
1.09B
54 days until earnings call
QNCX
Price
$1.66
Change
-$0.06 (-3.49%)
Updated
Jan 17 closing price
Capitalization
73.04M
45 days until earnings call
Ad is loading...

LQDA vs QNCX

Header iconLQDA vs QNCX Comparison
Open Charts LQDA vs QNCXBanner chart's image
Liquidia
Price$12.89
Change+$0.38 (+3.04%)
Volume$1.07M
Capitalization1.09B
Quince Therapeutics
Price$1.66
Change-$0.06 (-3.49%)
Volume$185.01K
Capitalization73.04M
LQDA vs QNCX Comparison Chart
Loading...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LQDA vs. QNCX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LQDA is a Hold and QNCX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (LQDA: $12.89 vs. QNCX: $1.66)
Brand notoriety: LQDA and QNCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LQDA: 131% vs. QNCX: 77%
Market capitalization -- LQDA: $1.09B vs. QNCX: $73.04M
LQDA [@Biotechnology] is valued at $1.09B. QNCX’s [@Biotechnology] market capitalization is $73.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LQDA’s FA Score shows that 1 FA rating(s) are green whileQNCX’s FA Score has 1 green FA rating(s).

  • LQDA’s FA Score: 1 green, 4 red.
  • QNCX’s FA Score: 1 green, 4 red.
According to our system of comparison, both LQDA and QNCX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LQDA’s TA Score shows that 3 TA indicator(s) are bullish while QNCX’s TA Score has 3 bullish TA indicator(s).

  • LQDA’s TA Score: 3 bullish, 6 bearish.
  • QNCX’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, QNCX is a better buy in the short-term than LQDA.

Price Growth

LQDA (@Biotechnology) experienced а +5.74% price change this week, while QNCX (@Biotechnology) price change was -7.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

LQDA is expected to report earnings on May 08, 2025.

QNCX is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LQDA($1.09B) has a higher market cap than QNCX($73M). LQDA YTD gains are higher at: 9.609 vs. QNCX (-11.230). QNCX has higher annual earnings (EBITDA): -33.93M vs. LQDA (-107.21M). LQDA has more cash in the bank: 204M vs. QNCX (47.8M). LQDA has less debt than QNCX: LQDA (2.69M) vs QNCX (15.4M). LQDA has higher revenues than QNCX: LQDA (15.6M) vs QNCX (0).
LQDAQNCXLQDA / QNCX
Capitalization1.09B73M1,495%
EBITDA-107.21M-33.93M316%
Gain YTD9.609-11.230-86%
P/E RatioN/AN/A-
Revenue15.6M0-
Total Cash204M47.8M427%
Total Debt2.69M15.4M17%
FUNDAMENTALS RATINGS
LQDA: Fundamental Ratings
LQDA
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
30
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LQDAQNCX
RSI
ODDS (%)
Bearish Trend 5 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
78%
Momentum
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 5 days ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
88%
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
86%
Bullish Trend 13 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
87%
N/A
Aroon
ODDS (%)
Bullish Trend 5 days ago
89%
Bullish Trend 5 days ago
86%
View a ticker or compare two or three
Ad is loading...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

LQDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LQDA has been loosely correlated with MTVA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LQDA jumps, then MTVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LQDA
1D Price
Change %
LQDA100%
+3.04%
MTVA - LQDA
44%
Loosely correlated
+2.91%
XERS - LQDA
30%
Poorly correlated
-0.62%
FOLD - LQDA
27%
Poorly correlated
+0.53%
PCVX - LQDA
26%
Poorly correlated
-2.88%
PLRX - LQDA
25%
Poorly correlated
-3.36%
More

QNCX and

Correlation & Price change

A.I.dvisor tells us that QNCX and MNPR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that QNCX and MNPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
-3.49%
MNPR - QNCX
29%
Poorly correlated
-6.36%
KOD - QNCX
28%
Poorly correlated
-6.15%
MDXG - QNCX
24%
Poorly correlated
+0.44%
LQDA - QNCX
24%
Poorly correlated
+3.04%
FENC - QNCX
22%
Poorly correlated
-1.60%
More